Novartis Hellas S.A.C.I., a company of the Novartis AG Group, has been active in Greece for more than 20 years. The Novartis Hellas legal entity includes the Pharmaceuticals, Oncology and Sandoz divisions with a capacity of approximately 430 people. The company is headquartered in Metamorfosi Attica, with offices also in Thessaloniki and Marousi (Sandoz).
Νovartis Pharmaceuticals και Novartis Oncology (Innovative Medicines):
Νovartis Pharmaceuticals και Novartis Oncology focus on patented innovative medicines in the fields of cardiovascular system and metabolism, immunology, dermatology and hepatology, central nervous system, respiratory system, ophthalmology, oncology and hematology for better outcomes for patients.
It is a leader in the fast growing industry of generic and biomedical formulas, allowing people from all over the world access to high quality medicines.
For more information about Novartis, visit: